Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma
Journal of Clinical Investigation · 01.04.2025 · 135 (7)
DOI: 10.1172/jci191422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2025. Verfasst von Qun Chen und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Pancreatic Neoplasms, Chemokine CCL2. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Metabolic reprogramming in pancreatic ductal adenocarcinoma (PDAC) fosters an immunosuppressive tumor microenvironment (TME) characterized by elevated lactate levels, which contribute to immune evasion and therapeutic resistance. In this issue of the JCI , Sun, Zhang, and colleagues identified nonhistone ENSA-K63 lactylation as a critical regulator that inactivates PP2A, activates STAT3/CCL2 signaling, recruits tumor-associated macrophages (TAMs), and suppresses cytotoxic T cell activity. Targeting ENSA-K63 lactylation or CCL2/CCR2 signaling reprograms the TME and enhances the efficacy of immune checkpoint blockade (ICB) in PDAC preclinical models. This work provides critical insights into the metabolic-immune crosstalk in PDAC and highlights promising therapeutic strategies for overcoming immune resistance and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NCI NIH HHS
Zitieren
APA
Chen, Q., Yuan, H., Bronze, M. S., & Li, M. (2025). Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. Journal of Clinical Investigation, 135(7). https://doi.org/10.1172/jci191422
Vancouver
Chen Q, Yuan H, Bronze MS, Li M. Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. Journal of Clinical Investigation. 2025;135(7). doi:10.1172/jci191422
BibTeX
@article{Chen2025,
author = {Chen, Qun and Yuan, Hao and Bronze, Michael S and Li, Min},
title = {Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {7},
doi = {10.1172/jci191422}
}
EUVIMED